Pages
Products
Services
CBpromise

Our promise to you:
Guaranteed product quality, expert customer support.

24x7 CUSTOMER SERVICE
CONTACT US TO ORDER

MicroRNA Agomir/ Antagomir Synthesis Service

OverviewChemical ModificationsCustom ServicesQuality AssuranceApplicationsTechnical Support

Overview

microRNAs (miRNAs) are endogenous small regulatory RNAs that play critical roles in gene expression, cell fate determination, metabolism, and disease progression. To investigate miRNA function through gain-of-function (overexpression) or loss-of-function (inhibition) studies, chemically modified miRNA mimics (agomirs) and antisense inhibitors (antagomirs) have become widely used and highly efficient tools. Creative Biogene provides one-stop Agomir / Antagomir synthesis services, covering the complete workflow from sequence design, chemical modification, purification, and quality control to final delivery, suitable for both cellular assays and in vivo functional studies.

Chemical modifications commonly used in oligonucleotides.Figure 1. Chemically modified agomir or antagomir.

Why Choose Agomir / Antagomir?

Compared to standard miRNA mimics or unmodified antisense oligonucleotides, chemically optimized agomirs and antagomirs offer distinct advantages:

  • Enhanced cellular uptake: Increased membrane affinity allows lower transfection reagent usage while improving transfection efficiency and reproducibility.
  • Improved in vivo stability and durability: Suitable for naked or minimally assisted delivery via intravenous, intraperitoneal, or local injection. Functional effects typically last at least one week, with some reports extending to several weeks.
  • High sequence specificity and target enrichment: Efficiently modulates target miRNAs or mimics endogenous regulatory activity.
  • Versatile and easy-to-use: Applicable for both in vitro transfection and direct in vivo administration.

Common Chemical Modifications

Our agomirs and antagomirs incorporate chemical enhancements to maximize stability, activity, and safety:

  • 3′ Cholesterol: Enhances hydrophobicity and plasma protein binding to improve cellular uptake and tissue distribution.
  • Phosphorothioate (PS) bonds at terminal positions: Introduced at both 5′ and 3′ ends to resist exonuclease and endonuclease degradation. Common schemes include 2 PS at 5′ and 4 PS at 3′.
  • 2′-O-Methyl (2′-O-Me) modifications: Full-length or site-specific, improving affinity and nuclease resistance while reducing nonspecific toxicity.

Custom Synthesis Services

Service TypeScalePurificationPurityPrice
miR-Down™ Antagomir2 ODHPLC≥95%Inquiry
Antagomir Negative Control2 ODHPLC≥95%Inquiry
miR-UP™ Agomir2 ODHPLC≥95%Inquiry
Agomir Negative Control2 ODHPLC≥95%Inquiry

Notes:

  • OD refers to the optical density representing synthesis yield; specify exact nmol/μg if needed.
  • HPLC purification is standard; optional PAGE or dual purification is available at additional cost.
  • Support for fluorescent labels (FAM/Cy3/Cy5), biotin, sterile filtration, and GMP-grade synthesis is available on request.

Quality Assurance and Analytical Validation

Each batch undergoes rigorous quality control, including:

  • Mass spectrometry (MALDI-TOF / ESI-MS): Confirms molecular weight and modification integrity.
  • Reverse-phase HPLC: Evaluates purity and provides chromatograms.
  • A260/A280 measurement: Assesses nucleic acid purity and concentration.
  • Optional sterility/endotoxin testing: Ensures suitability for in vivo studies.

Experimental Applications

In vitro (cell-based) studies

  • Agomirs: Short- or mid-term overexpression to simulate mature miRNA activity and induce downstream gene changes; applied in phenotype validation, reporter assays, and pathway studies.
  • Antagomirs: Block endogenous miRNA function, enabling functional assessment, network analysis, and physiological studies.

In vivo (animal) studies

  • Chemically modified agomirs/antagomirs with cholesterol and terminal PS modifications demonstrate enhanced stability and tissue accumulation.
  • Administration routes include intravenous, tail vein, intraperitoneal, intramuscular, or local injection, supporting disease models and pharmacological studies. Literature reports sustained miRNA inhibition and phenotypic changes in mouse models.

Case Study

Researchers used custom miRNA agomirs and antagomirs synthesized by Creative Biogene to modulate miRNA expression in skeletal muscle. AntagomiR-22-3p and agomiR-127 were applied to enhance myoblast proliferation in vitro and induce muscle hypertrophy in vivo. Treatments effectively regulated target miRNAs and downstream genes such as KIF3B and ACVR2a, leading to distinct proteomic and muscle fiber changes. The study demonstrated the use of synthetic miRNA modulators to influence gene expression and muscle development.

Myoblast proliferation over time in cultures treated with 500 nM antagomiRs (ANT-22-3p, −27a, −29a, and −133). Figure 2. Myoblast proliferation over time in cultures treated with 500 nM antagomiRs (ANT-22-3p, −27a, −29a, and −133). (Greene MA, et al., 2023)

Technical Support

For sequence design, dosing recommendations, or in vivo delivery planning, provide your experimental goal, cell line/animal model, and desired endpoints. Creative Biogene's technical team offers feasible design and optimization guidance to maximize success and efficiency.

Our mission is to provide stable, reproducible, high-quality miRNA modulators. Whether for mechanistic studies, pharmacological validation, or preclinical models, Creative Biogene's Agomir / Antagomir synthesis services deliver technical reliability and efficient support. Contact us for customized solutions and quotations.

Related Services

Custom miRNA Microarray Service

circRNA-miRNA/RBP Interaction Analysis Service

miRNA Service

FAQ

Q1: Can agomirs be used in vivo without a delivery vector?

A1: Most cholesterol- and PS-modified agomirs/antagomirs can be administered intravenously or intraperitoneally without carriers, but dosage, injection route, and animal model affect efficiency and distribution. Small-scale dose escalation and tissue distribution validation are recommended.

Q2: Can human miRNAs be used directly in mice/rats?

A2: Highly conserved miRNAs may work across species; divergent sequences may fail to bind or produce different phenotypes. Verify sequence conservation and perform in vitro validation prior to in vivo studies.

Q3: How long for agomirs to enter cells without transfection reagents?

A3: Unmodified small RNAs enter cells poorly. Cholesterol and other lipophilic modifications improve passive uptake, but efficiency depends on cell type and modification; transfection reagents or electroporation are recommended for controlled, efficient delivery.

Q4: How to design effective Agomirs or Antagomirs?

A4: Select mature miRNA sequences from authoritative databases like miRBase, considering sequence conservation for cross-species use. Design antagomirs as antisense to the mature miRNA, while agomir guide and passenger strands should mimic the seed region and base-pairing of the endogenous miRNA. Apply chemical modifications such as terminal PS bonds, 3′ cholesterol, and full-length 2′-O-Me to enhance stability and affinity; alternatives like LNA or 2′-F can optimize performance or reduce toxicity. Always include validated positive and negative controls to ensure reproducibility and accurate result interpretation.

Reference:

  1. Greene MA, Worley GA, et al. Use of AgomiR and AntagomiR technologies to alter satellite cell proliferation in vitro, miRNA expression, and muscle fiber hypertrophy in intrauterine growth-restricted lambs. Front Mol Biosci. 2023 Nov 3;10:1286890.
* For research use only. Not intended for any clinical use.
Quick Inquiry